Tumor Ablation Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Tumor Ablation Market By Function (Automated/Robotic ablation, Conventional ablation devices), By Technology (Hyperthermic ablation, Radiofrequency ablation, Microwave ablation, Laser ablation, Ultrasound ablation, Cryoablation), By Application (Primary lung cancer, Metastatic diseases, Pain palliation), By End User (Hospitals, Oncology institutes, Diagnostic centres) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Tumor Ablation Market size was estimated at USD 620.71 million in 2021, growing at a CAGR of 13.2% during the forecast period 2021-2027. Tumor ablation is a minimally invasive surgical method that enables treats solid tumors in which special probes are used to freeze or burn cancers without the usual surgery. The tumor ablation method is guided by the help of a CT scan, MRI Scan and ultrasound to locate and position the needle probe into the tumor which requires a tiny hole of 3mm diameter to introduce the probe. When the probe is within cancer it is attached to a generator that burns and freezes cancer. The most common cancers that are treated by this method are lung cancer, renal cancer, and liver cancer. Innovations in resources and technologies required in tumor ablation have provided ample opportunities for various pharma and electronics companies to work for the betterment of currently available technologies. Innovations such as high intensity focused ultrasound (HIFU), irreversible electroporation and image-guided procedures are rising demand for adaptation of tumor ablation. Moreover, increased focus on R&D investments, product developments, and launches, acquisitions, mergers, and collaborations are few strategies adopted by the players in the Tumor Ablation Market.

Key Developments:

In 2016, Medtronic launched Barrx360 express radiofrequency ablation balloon catheter to treat Barrett’s oesophagus

In 2016 May, BTG Plc. has acquired Galil Medical, cryoablation systems, and needles manufacturer.

In 2015 January, Medtronic acquired Covidien which has improved its product portfolio of tumor ablation products.

Tumor Ablation Market

MARKET SUMMARY
-
13.2% CAGR
  • Study Period– 2022– 2028
  • Base Year– 2021
  • CAGR– 13.2%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Tumor Ablation Market

  • The report on the global  tumor ablation market gives historical, current, and future market sizes (US$ Mn) on basis of function, technology, application, end user and region.
  • The global tumor ablation market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players

 

  • Angiodynamics, Inc. (U.S.)
  • BTG International Ltd (UK)
  • Healthtronics, Inc. (U.S.)
  • Mermaid Medical, Inc. (Denmark)
  • Neuwave Medical, Inc. (U.S.)
Tumor Ablation Market Drivers

Increasing in a number of cancer cases and rise in geriatric population are the major factors which are attributing for the growth of tumour ablation market. As per the WHO statistics, cancer accounts for 13% of deaths globally every year, moreover, 70% increase in cancer incidences is anticipated over the next couple of decades. The global geriatric population is anticipated to nearly double from 12% to 22% from 2015 to 2022. Furthermore, increase in the number of hospitals, ablation and surgical centers, less procedural costs associated with radiofrequency ablation tumour and advanced technologies in ablation devices, improved healthcare expenditure, growing awareness, and increased government support are the few more factors which expected to boost the growth of tumour ablation market globally. However, stringent regulatory framework, prolonged time of approvals for product launching and cost containment measures are expected to hamper the growth of tumour ablation market.


North-America got significant share

Tumor Ablation Market

Tumour Ablation Market is segmented into North America, Asia-Pacific, Europe, and the Middle East & Africa, Latin America. North America holds the largest share in tumour ablation market followed by Europe owing to the high incidence and prevalence of major cancers such as liver, kidney, lung and bone metastasis, increase in inclination towards minimally invasive procedures for treating cancer, the rise in government funds for cancer research. According to the reports of American Cancer Society, annual cancer incidences in U.S are 300.2 per 100,000 people and 296.6 cases per 100,000 people in Canada. Asia Pacific is anticipated to show significant growth during the foresee period owing to large population pool, growing economic developments in countries like China and India and improved healthcare infrastructure.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Tumor Ablation Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

 

  1. Executive Summary
  2. Global Tumour Ablation Market Introduction
    • Global Tumour Ablation Market – Taxonomy
    • Global Tumour Ablation Market –Definitions
      • Function
      • Technology
      • Application
      • End User
  1. Global Tumour Ablation Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Tumour Ablation Market Dynamic Factors – Impact Analysis
    • Global Tumour Ablation Market – Competition Landscape
    • Epidemiology
  2. Global Tumour Ablation Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Tumour Ablation Market, By Function, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Automated/Robotic ablation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Conventional ablation devices
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Tumour Ablation Market Forecast, By Technology,2013 – 2017 and Forecast, 2018 – 2024
    • Hyperthermic ablation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Radiofrequency ablation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Microwave ablation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laser ablation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ultrasound ablation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cryoablation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Tumour Ablation Market Forecast, By Application, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Primary lung cancer
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Metastatic diseases
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pain palliation
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Tumour Ablation Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Oncology institutes
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic centres
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Tumour Ablation Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Tumour Ablation Market – Opportunity Analysis Index, By Function, By Technology, By Application, By End User and Region, 2018 – 2024
  2. North America Tumour Ablation MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Function Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Automated/Robotic ablation
      • Conventional ablation devices
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hyperthermic ablation
      • Radiofrequency ablation
      • Microwave ablation
      • Laser ablation
      • Ultrasound ablation
      • Cryoablation
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Primary lung cancer
      • Metastatic diseases
      • Pain palliation
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Oncology institutes
      • Diagnostic centres
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Tumour Ablation Market – Opportunity Analysis Index, By Function, By Technology, By Application, By End User and Country, 2018 – 2024
    • North America Tumour Ablation Market Dynamics – Trends
  3. Europe Tumour Ablation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Function Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Automated/Robotic ablation
      • Conventional ablation devices
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hyperthermic ablation
      • Radiofrequency ablation
      • Microwave ablation
      • Laser ablation
      • Ultrasound ablation
      • Cryoablation
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Primary lung cancer
      • Metastatic diseases
      • Pain palliation
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Oncology institutes
      • Diagnostic centres
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Tumour Ablation Market – Opportunity Analysis Index, By Function, By Technology, By Application, By End User and Country, 2018 – 2024
    • Europe Tumour Ablation Market Dynamics – Trends
  4. Asia-Pacific Tumour Ablation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Function Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Automated/Robotic ablation
      • Conventional ablation devices
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hyperthermic ablation
      • Radiofrequency ablation
      • Microwave ablation
      • Laser ablation
      • Ultrasound ablation
      • Cryoablation
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Primary lung cancer
      • Metastatic diseases
      • Pain palliation
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Oncology institutes
      • Diagnostic centres
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Tumour Ablation Market – Opportunity Analysis Index, By Function, By Technology, By Application, By End User and Country, 2018 – 2024
    • Asia-Pacific Tumour Ablation Market Dynamics – Trends
  5. Latin America Tumour Ablation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Function Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Automated/Robotic ablation
      • Conventional ablation devices
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hyperthermic ablation
      • Radiofrequency ablation
      • Microwave ablation
      • Laser ablation
      • Ultrasound ablation
      • Cryoablation
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Primary lung cancer
      • Metastatic diseases
      • Pain palliation
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Oncology institutes
      • Diagnostic centres
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Tumour Ablation Market – Opportunity Analysis Index, By Function, By Technology, By Application, By End User and Country, 2018 – 2024
    • Latin America Tumour Ablation Market Dynamics – Trends
  6. Middle East and Africa Tumour Ablation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Function Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Automated/Robotic ablation
      • Conventional ablation devices
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hyperthermic ablation
      • Radiofrequency ablation
      • Microwave ablation
      • Laser ablation
      • Ultrasound ablation
      • Cryoablation
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Primary lung cancer
      • Metastatic diseases
      • Pain palliation
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Oncology institutes
      • Diagnostic centres
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Tumour Ablation Market – Opportunity Analysis Index, By Function, By Technology, By Application, By End User and Country, 2018 – 2024
    • MEA Tumour Ablation Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Function& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Boston Scientific Corporation (U.S.)
      • Angiodynamics, Inc. (U.S.)
      • BTG International Ltd (UK)
      • Healthtronics, Inc. (U.S.)
      • Medtronic, Plc (U.S.)
      • EDAP TMS S.A. (France)
      • Mermaid Medical, Inc. (Denmark)
      • Neuwave Medical, Inc. (U.S.)
      • Sonacare Medical, LLC (U.S.)
      • Mesonix, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Boston Scientific Corporation (U.S.)
  • Angiodynamics, Inc. (U.S.)
  • BTG International Ltd (UK)
  • Healthtronics, Inc. (U.S.)
  • Medtronic, Plc (U.S.)
  • EDAP TMS S.A. (France)
  • Mermaid Medical, Inc. (Denmark)
  • Neuwave Medical, Inc. (U.S.)
  • Sonacare Medical, LLC (U.S.)
  • Mesonix, Inc. (U.S.)

Description

Tumor Ablation Market size was estimated at USD 620.71 million in 2021, growing at a CAGR of 13.2% during the forecast period 2021-2027. Tumor ablation is a minimally invasive surgical method that enables treats solid tumors in which special probes are used to freeze or burn cancers without the usual surgery. The tumor ablation method is guided by the help of a CT scan, MRI Scan and ultrasound to locate and position the needle probe into the tumor which requires a tiny hole of 3mm diameter to introduce the probe. When the probe is within cancer it is attached to a generator that burns and freezes cancer. The most common cancers that are treated by this method are lung cancer, renal cancer, and liver cancer. Innovations in resources and technologies required in tumor ablation have provided ample opportunities for various pharma and electronics companies to work for the betterment of currently available technologies. Innovations such as high intensity focused ultrasound (HIFU), irreversible electroporation and image-guided procedures are rising demand for adaptation of tumor ablation. Moreover, increased focus on R&D investments, product developments, and launches, acquisitions, mergers, and collaborations are few strategies adopted by the players in the Tumor Ablation Market.

Key Developments:

In 2016, Medtronic launched Barrx360 express radiofrequency ablation balloon catheter to treat Barrett’s oesophagus

In 2016 May, BTG Plc. has acquired Galil Medical, cryoablation systems, and needles manufacturer.

In 2015 January, Medtronic acquired Covidien which has improved its product portfolio of tumor ablation products.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX